Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,329,336
+$15,660,423 QoQ
Shares Held
655,140
+24.1% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,415,471 | $101,715,746 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
260,605 | $43,922,366 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
2,649,866 | $38,396,558 | |
| 4 | ALKS |
Alkermes plc.
This page
|
655,140 | $34,329,336 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
300,967 | $33,389,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
58,580 | $31,740,401 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,180,709 | $29,057,248 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
437,192 | $27,958,428 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,329,336 | 655,140 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,668,913 | 527,967 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $12,040,633 | 430,330 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $22,836,090 | 761,203 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $32,486,025 | 1,135,478 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,226,229 | 127,990 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,269,104 | 217,980 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,184,309 | 149,493 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,061,851 | 85,554 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,199,111 | 229,003 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $6,767,478 | 243,961 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,165,919 | 434,342 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,636,170 | 275,916 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $4,627,247 | 164,145 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,173,274 | 159,712 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,529,729 | 202,854 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $4,618,075 | 155,021 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,532,610 | 58,252 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $2,541,015 | 109,244 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,809,043 | 58,659 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $1,359,952 | 55,463 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $794,012 | 42,506 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $11,092,180 | 555,999 | Shares | Defined | 2021-02-10 | |
| 2020-06-30 | $1,380,380 | 71,117 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $14,959,668 | 1,037,425 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||